http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03080804-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_743747a9f4910dac212531473ceaf68f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3305e6966377a48ded8df7ffa7b44eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41518ba53aaa1f3472837e42105cb8e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2db1eb4f46cbdcc40a8795011a1fe210 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12d1c6e8e1627fc9cfe42a28bcf22a43 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 |
| filingDate | 2003-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0f4f2a17c65b261d1d9a7013b6e5ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_789d80b30b8721de59d77c49fe0883de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc1c9964c8e0547283dd7dc7bee3ae2 |
| publicationDate | 2003-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-03080804-A2 |
| titleOfInvention | Regulation of ins(3456)p4 signalling by a reversible kinase/phosphatase and methods and compositions related thereto |
| abstract | Provided is a method of increasing 3,4,5,6-tetrakisphosphate by increasing the activity of inositol 1,3,4,5,6 pentakisphosphate 1-phosphatase, and a method of decreasing 3,4,5,6-tetrakisphosphate by decreasing the activity of inositol 1,3,4,5,6 pentakisphosphate 1-phosphatase. A method of reducing salt, fluid or mucous secretion in a subject, comprising increasing the activity of inositol 1,3,4,5,6 pentakisphosphate 1-phosphatase in the subject is provided. A method of treating a disease that is exacerbated by salt, fluid or mucous secretion is also provided, comprising increasing the activity of inositol 1,3,4,5,6 pentakisphosphate 1phosphatase in a subject having a disease that is exacerbated by mucous, whereby mucous secretion is reduced and the disease is treated. Also provided is method of increasing salt and fluid secretion in a subject, comprising decreasing the activity of inositol 1,3,4,5,6 pentakisphosphate 1-phosphatase in the subject. A method of treating a disease that is treated by increased salt and fluid secretion is provided, comprising decreasing the activity of inositol 1,3,4,5,6 pentakisphosphate 1-phosphatase in a subject having a disease that is treated by increased salt and fluid secretion, whereby salt and fluid secretion is increased and the disease is treated. |
| priorityDate | 2002-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 863.